Pharyngitis News and Research

RSS
Focus Diagnostics announces FDA clearance for Simplexa Group A Strep Direct Kit

Focus Diagnostics announces FDA clearance for Simplexa Group A Strep Direct Kit

Fusobacterium necrophorum often causes severe sore throats in young adults

Fusobacterium necrophorum often causes severe sore throats in young adults

Study: 45% of RTI patients inappropriately prescribed antibiotics in outpatient settings

Study: 45% of RTI patients inappropriately prescribed antibiotics in outpatient settings

Roche announces launch of cobas Liat System for on-demand testing in different settings

Roche announces launch of cobas Liat System for on-demand testing in different settings

UCB, Dermira enter into licensing agreement for development, commercialization of Cimzia

UCB, Dermira enter into licensing agreement for development, commercialization of Cimzia

Tonsillectomy in adults improves quality of life

Tonsillectomy in adults improves quality of life

Research may lead to potential treatment for deadly bacterial infections

Research may lead to potential treatment for deadly bacterial infections

Celgene subsidiary presents REVLIMID study results on lymphoma at ASH annual meeting

Celgene subsidiary presents REVLIMID study results on lymphoma at ASH annual meeting

Research roundup: Pricing and the SHOP exchange; health use in rural vs. urban areas; the health law and AIDS care

Research roundup: Pricing and the SHOP exchange; health use in rural vs. urban areas; the health law and AIDS care

Once-daily prescription medicine for COPD now available throughout the U.S.

Once-daily prescription medicine for COPD now available throughout the U.S.

FDA approves Cimzia (certolizumab pegol) for active psoriatic arthritis

FDA approves Cimzia (certolizumab pegol) for active psoriatic arthritis

Respiratory infection antibiotic guidance often ignored

Respiratory infection antibiotic guidance often ignored

Celgene to discontinue treatment with REVLIMID in phase III ORIGIN trial

Celgene to discontinue treatment with REVLIMID in phase III ORIGIN trial

Social media and DNA fingerprinting played important role in alerting strep outbreak

Social media and DNA fingerprinting played important role in alerting strep outbreak

Phase III study: REVLIMID meets primary endpoint in patients newly diagnosed with multiple myeloma

Phase III study: REVLIMID meets primary endpoint in patients newly diagnosed with multiple myeloma

European Commission amends marketing authorisation for Celgene's REVLIMID

European Commission amends marketing authorisation for Celgene's REVLIMID

Educating pediatricians on appropriate antibiotic usage can improve outcomes in children’s infections

Educating pediatricians on appropriate antibiotic usage can improve outcomes in children’s infections

Study: Intervention improves adherence to prescribing guidelines for pediatric bacterial ARTIs

Study: Intervention improves adherence to prescribing guidelines for pediatric bacterial ARTIs

Boehringer Ingelheim updates HCPs, patients on COMBIVENT RESPIMAT Inhalation Spray

Boehringer Ingelheim updates HCPs, patients on COMBIVENT RESPIMAT Inhalation Spray

FDA approves Lupin Pharmaceuticals' SUPRAX for Oral Suspension

FDA approves Lupin Pharmaceuticals' SUPRAX for Oral Suspension